| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.4 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |